MEDIA INQUIRES CONTACT:
Renee Young, National Public Relations
(212) 303- 8140
JERUSALEM, ISRAEL— The Hadassah Medical Organization Board of Directors has approved the appointment of Erez Meltzer, 59, as Chairperson of the Board. He was selected from among top-tier candidates presented by Hadassah, the Women’s Zionist Organization of America, to the Government of Israel representatives and was approved by the Ministries of Health and Finance.
Meltzer is a successful business leader and a teaching professor of management and crisis intervention. Today he serves as the CEO of MIS dental implants, a company that markets its products in over sixty countries. His previous managerial experience includes heading the Africa-Israel Investments, and serving as president and CEO of Netafim, the renowned drip irrigation company, which he brought through a recovery period to double its sales from $200 million to $400 million annually. Before serving at Netafim, Meltzer was president and CEO of Creo Scitex, and was responsible for the merger of the two companies. He was the first CEO of the merged company, which had 4,000 employees and $700 million in sales.
He is an internationally recognized expert on global management and leadership. He teaches crisis management in the Executive MBA program at the Faculty of Medicine at the Tel- Aviv University, and also lectures at the IDC Herzliya and other universities. Meltzer studied mathematics, economics and business administration at the Hebrew University of Jerusalem and Boston University. He completed advanced business administration courses at Harvard University.
A married father of four and grandfather, Meltzer was born in the United States and educated in both America and Israel. He served as an officer in the IDF Armored Corps and has been recognized internationally for his social service.
Marcie Natan, National President of Hadassah the Women’s Organization of America, said, “This appointment is an important step in implementing the recovery plan with the Israeli Government and in moving the Hadassah Medical Organization forward. We know that the public debate about many aspects of streamlining is a natural, if not always helpful part of any recovery process. We encourage all parties to unite behind this next step in moving ahead.”
As part of the new governance structure of HMO a search committee will soon start the process to identify a permanent Director General. In parallel a new Board of Directors will be put in place to begin in January 2015.
Hadassah is the largest Jewish women’s organization in the United States. With 330,000 members, associates and supporters across the country, Hadassah brings Jewish women together to effect change and advocate on criticalissues such as medical care and research, women's empowerment, and the security of Israel. Through the Hadassah Medical Organization's (HMO) two hospitals, the world-renowned trauma center and the leading research facility in Jerusalem, Hadassah supports the delivery of exemplary patient care to over a million people every year. HMO serves without regard to race, religion or nationality and earned a Nobel Peace Prize Nomination in 2005 for building “bridges to peace” through equality in medical treatment. For more information, visit www.hadassah.org.